---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-005030"
form_type: "8-K"
ticker: "OCGN"
cik: "0001372299"
company_name: "Ocugen, Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T22:46:26.115499+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "low"
source: SEC EDGAR
---

# Ocugen posts clinical presentation showing 84% reduction in mean total atrophy area in treated group

## Summary
- Presentation reports mean change in total atrophy area from baseline: 0.12±0.36 mm² (treated) vs 0.73±0.26 mm² (untreated), an 84% difference.
- A 44% efficacy metric also cited; specific endpoint not fully legible from exhibit.
- Presentation posted on website and may be used in investor discussions; no formal press release or guidance provided.

## SEC filing metadata
- accession: 0001628280-25-005030
- form_type: 8-K
- ticker: OCGN
- cik: 0001372299
- company_name: Ocugen, Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372299/000162828025005030/0001628280-25-005030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372299/000162828025005030/ocgn-20250212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-005030
- JSON: https://secwatch.observer/filing/0001628280-25-005030.json
- Plain text: https://secwatch.observer/filing/0001628280-25-005030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.